Top 5 CRISPR Stocks To Invest In
Exact Sciences Corporation (NASDAQ:EXAS) specializes in cancer screening and diagnostic test products, operating both in the United States and internationally.
Regeneron Pharmaceuticals Inc. (REGN)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
30 Most Valuable Drug Companies in 2024
In this article, we will take a look at the 30 most valuable drug companies in 2024.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2023 Earnings Call Transcript
Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $10.19 EPS, expectations were $10.43. Regeneron Pharmaceuticals, Inc.
5 Most Promising Gene Editing Stocks According to Hedge Funds
In this piece, we will take a look at the five most promising gene editing stocks according to hedge funds.
30 Largest Pharmaceutical Companies in the World
In this article, we will be taking a look at the 30 largest pharmaceutical companies in the world.
JP Morgan's Top 15 Stock Picks for 2023 and Now
In this piece, we will take a look at JP Morgan's top 15 stock picks for 2023 and most recent stock picks.
Top 20 Drug Companies in the US by Revenue
Following the Covid-19 pandemic, which drastically altered the way of living, the top pharmaceutical or drug companies in the world became the center of attention for people everywhere due to the spike...
Regeneron Pharmaceuticals (REGN): Bronte Capital’s Biggest Winner of This Quarter
Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2023 investor letter. A copy of the same can be downloaded here.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Regeneron Pharmaceuticals Third Quarter 2023 Earnings Conference Call. My name is Shannon, and I will be your operator for today's call.
5 Cheap Biotech Stocks Smart Investors Are Piling Into
In this piece, we will take a look at five cheap biotechnology stocks that smart investors are piling into.
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
